Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: CBIT+TMS R33 Phase [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating CBIT combined with transcranial magnetic stimulation for Tourette syndrome, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Minnesota | Conditions: Tics, Tourette Syndrome | Phase 2 | Status: RECRUITING